Evidence-Based Evaluation and Management of Cognitive Impairment in Dementia With Lewy Bodies

Alka Khera; Barbara E. Stopschinski; Hsueh Sheng Chiang

doi:10.3928/00485713-20220901-01

Evidence-Based Evaluation and Management of Cognitive Impairment in Dementia With Lewy Bodies

Alka Khera, Barbara E. Stopschinski, Hsueh Sheng Chiang

Research output: Contribution to journal › Article › peer-review

Abstract

Dementia is a functional decline due to cognitive impairment, and its presence is required to make a diagnosis of dementia with Lewy bodies (DLB). Evaluation and management of cognitive impairment in DLB is complex and requires consideration of cognitive fluctuations as well as motor and behavioral symptoms. This article reviews the literature surrounding evaluation and management of cognitive impairment in DLB, highlighting the specific cognitive profile typically seen in early DLB as well as the available evidence for management of these symptoms. There are several pharmacological and nonpharmacological treatment strategies that are currently under investigation, and these are reviewed as well. [Psychiatr Ann. 2022;52(10):404-409.].

Original language	English (US)
Pages (from-to)	404-409
Number of pages	6
Journal	Psychiatric Annals
Volume	52
Issue number	10
DOIs	https://doi.org/10.3928/00485713-20220901-01
State	Published - Oct 1 2022

ASJC Scopus subject areas

Psychiatry and Mental health

Access to Document

10.3928/00485713-20220901-01

Cite this

@article{72fbb80eb58b47129a690ab94bc5c310,

title = "Evidence-Based Evaluation and Management of Cognitive Impairment in Dementia With Lewy Bodies",

abstract = "Dementia is a functional decline due to cognitive impairment, and its presence is required to make a diagnosis of dementia with Lewy bodies (DLB). Evaluation and management of cognitive impairment in DLB is complex and requires consideration of cognitive fluctuations as well as motor and behavioral symptoms. This article reviews the literature surrounding evaluation and management of cognitive impairment in DLB, highlighting the specific cognitive profile typically seen in early DLB as well as the available evidence for management of these symptoms. There are several pharmacological and nonpharmacological treatment strategies that are currently under investigation, and these are reviewed as well. [Psychiatr Ann. 2022;52(10):404-409.].",

author = "Alka Khera and Stopschinski, {Barbara E.} and Chiang, {Hsueh Sheng}",

year = "2022",

month = oct,

day = "1",

doi = "10.3928/00485713-20220901-01",

language = "English (US)",

volume = "52",

pages = "404--409",

journal = "Psychiatric Annals",

issn = "0048-5713",

publisher = "Slack Incorporated",

number = "10",

}

TY - JOUR

T1 - Evidence-Based Evaluation and Management of Cognitive Impairment in Dementia With Lewy Bodies

AU - Khera, Alka

AU - Stopschinski, Barbara E.

AU - Chiang, Hsueh Sheng

PY - 2022/10/1

Y1 - 2022/10/1

N2 - Dementia is a functional decline due to cognitive impairment, and its presence is required to make a diagnosis of dementia with Lewy bodies (DLB). Evaluation and management of cognitive impairment in DLB is complex and requires consideration of cognitive fluctuations as well as motor and behavioral symptoms. This article reviews the literature surrounding evaluation and management of cognitive impairment in DLB, highlighting the specific cognitive profile typically seen in early DLB as well as the available evidence for management of these symptoms. There are several pharmacological and nonpharmacological treatment strategies that are currently under investigation, and these are reviewed as well. [Psychiatr Ann. 2022;52(10):404-409.].

AB - Dementia is a functional decline due to cognitive impairment, and its presence is required to make a diagnosis of dementia with Lewy bodies (DLB). Evaluation and management of cognitive impairment in DLB is complex and requires consideration of cognitive fluctuations as well as motor and behavioral symptoms. This article reviews the literature surrounding evaluation and management of cognitive impairment in DLB, highlighting the specific cognitive profile typically seen in early DLB as well as the available evidence for management of these symptoms. There are several pharmacological and nonpharmacological treatment strategies that are currently under investigation, and these are reviewed as well. [Psychiatr Ann. 2022;52(10):404-409.].

UR - http://www.scopus.com/inward/record.url?scp=85140222966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140222966&partnerID=8YFLogxK

U2 - 10.3928/00485713-20220901-01

DO - 10.3928/00485713-20220901-01

M3 - Article

AN - SCOPUS:85140222966

SN - 0048-5713

VL - 52

SP - 404

EP - 409

JO - Psychiatric Annals

JF - Psychiatric Annals

IS - 10

ER -

Evidence-Based Evaluation and Management of Cognitive Impairment in Dementia With Lewy Bodies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this